Apiksaban Teva 2,5 mg filmom obložene tablete
| Name | Apiksaban Teva 2,5 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-445465993 |
| Active Substance | apiksaban |
| Composition | jedna filmom obložena tableta sadrži 2,5 mg apiksabana |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Combino Pharm (Malta) Ltd., Birzebbuga, Malta |
| Marketing Authorisation Holder | TEVA GmbH, Graf-Arco-Str. 3, Ulm, Njemačka |
| Marketing Authorisation Date | 05.10.2022 |
| MA Period of Validity | 05.10.2027 |
| Classification Number | UP/I-530-09/22-01/121 |
| Registration Number | 381-12-01/154-22-06 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | B01AF02 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
| Educational materials for healthcare professionals |
Vodič za propisivače, verzija 5 |
